cureflo
1 / 4Páginas

Continuous Renal Replacement Therapy (CRRT) ASAHI KASEI MEDICAL CO., LTD. A Pioneer in Blood Purification

CUREFLO is intended for patients with renal failure who also suffer from severe complications, such as multiple organ failure or cardiac and circulatory problems, including cardiac insufficiency and edema, who are not adequately treated by intermittent dialysis therapy. CUREFLO is used to correct and purify body fluid through continuous hemofiltration (normally in excess of 10 hrs.). Asahi's high flux polysulfone membrane specially developed for CRRT with: • High permeability and sharp cut-off curve from microporous gradient structure • Superior biocompatibility • Long patency of filter...

Superior biocompatibility The change of WBC, C3a and granulocyte elastase is very small during treatment. Granulocyte elastase ln-house data Long filter life Clinical data

ln-house data Floris M, Marchionna N, Clementi A, Kim JC, Cruz DN, Nalesso F, Zanella M, Garzotto F, de Cal M, Virzi GM, Brendolan A, Ronco C. Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy. 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101, Japan ASAHIKASEI MEDICAL EUROPE GmbH Herriotstrasse 1, 60528 Frankfurt am Main, Germany ASAHI KASEI MEDICAL AMERICA INC. 3570 Winchester Road, Suite 101, Memphis, Tennessee 38118, USA Copyright©2012 Asahi Kasei Medical Co., Ltd. Printed in Japan No.2012.11.7632